Insulin-like growth factor-binding protein 7 accelerates hepatic steatosis and insulin resistance in non-alcoholic fatty liver disease.

In conclusion, our study demonstrates that IGFBP7 contributes to hepatic steatosis and insulin resistance in NAFLD development, which might serve as a novel therapeutic agent for the treatment of NAFLD. This article is protected by copyright. All rights reserved.
PMID: 31397492 [PubMed - as supplied by publisher]

Source: Clinical and Experimental Pharmacology and Physiology - August 8, 2019 Category: Drugs & Pharmacology Authors: Yan H, Li T, Wang Y, Li H, Xu J, Lu X Tags: Clin Exp Pharmacol Physiol Source Type: research